News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
30 May 24
Movers
Jaguar Health And Magdalena Biosciences Executes Out-License Deal With For Botanical Drug Candidate for Schizophrenia
29 May 24
Biotech, News, General
What's Going On With Jaguar Health Stock?
23 May 24
News, Movers
Dow Falls Over 150 Points; Sohu Posts Q1 Loss
20 May 24
Earnings, Equities, News, Eurozone, Commodities, Intraday Update, Markets, Trading Ideas
Why Virios Therapeutics Shares Are Trading Lower By Around 48%? Here Are Other Stocks Moving In Monday's Mid-Day Session
20 May 24
News, Intraday Update, Markets, Movers
12 Health Care Stocks Moving In Monday's Intraday Session
20 May 24
Movers
Why Jaguar Health Stock Is Tanking
20 May 24
News, Penny Stocks, Movers
Nasdaq Surges 100 Points; Wix.com Shares Jump Following Q1 Results
20 May 24
US Stocks Mixed; Li Auto Shares Plummet After Q1 Results
20 May 24
Earnings, Equities, News, Eurozone, Commodities, Intraday Update, Markets, Trading Ideas
Why Wix.com Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving Premarket
20 May 24
News, Pre-Market Outlook, Markets, Movers
12 Health Care Stocks Moving In Monday's Pre-Market Session
20 May 24
Movers
12 Health Care Stocks Moving In Friday's After-Market Session
17 May 24
Movers
Peering Into Jaguar Health's Recent Short Interest
9 May 24
Short Sellers, Short Ideas, Trading Ideas
Jaguar Health Announces Submission Of Clinical Trial Applications For Crofelemer To Treat Rare Disease Indications Microvillus Inclusion Disease And Short Bowel Syndrome In Europe
9 May 24
Biotech, News, Global, General
FDA Conditionally Approves Jaguar Health's Prescription Drug Crofelemer For Chemotherapy-Induced Diarrhea In Dogs
6 May 24
Biotech, News, FDA, General
12 Health Care Stocks Moving In Friday's Pre-Market Session
3 May 24
Movers
Why Apple Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket
3 May 24
News, Pre-Market Outlook, Markets, Movers, Trading Ideas
12 Health Care Stocks Moving In Thursday's After-Market Session
2 May 24
Movers
12 Health Care Stocks Moving In Thursday's Intraday Session
2 May 24
Movers
Why Nucor Shares Are Trading Lower? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
23 Apr 24
News, Intraday Update, Markets, Movers
Press releases
Jaguar Health Executes Out-License Deal with Joint Venture Magdalena Biosciences for Botanical Drug Candidate for Schizophrenia
29 May 24
News, Press Releases
Investigator-Initiated Trial of Jaguar Health's Crofelemer Yields Positive Results for Functional Diarrhea
28 May 24
News, Press Releases
Jaguar Health to Initiate Commercial Footprint in Cancer Supportive Care at American Society of Clinical Oncology (ASCO) Annual Meeting with Exhibit Booth for FDA-Approved Gelclair Oral Mucositis Product
23 May 24
News, Press Releases
Jaguar Health, Inc. Announces Reverse Stock Split
17 May 24
News, Press Releases
Jaguar Health Reports First Quarter 2024 Financial Results
14 May 24
Earnings, Press Releases
REMINDER: Jaguar Health to Hold Investor Webcast Tuesday, May 14th at 8:30 AM Eastern Regarding Q1 2024 Financials & Corporate Updates
13 May 24
News, Press Releases
Jaguar Health Announces Submission of Clinical Trial Applications for Crofelemer for the Rare Disease Indications Microvillus Inclusion Disease (MVID) and Short Bowel Syndrome (SBS) in Europe
9 May 24
News, Press Releases
Jaguar Health to Hold Investor Webcast Tuesday, May 14th at 8:30 AM Eastern Regarding Q1 2024 Financials & Corporate Updates
8 May 24
News, Press Releases
Crofelemer, Jaguar Health's Prescription Drug Conditionally Approved by the FDA for Chemotherapy-Induced Diarrhea in Dogs, is the Subject of the Company's Investigational New Animal Drug Application for the Indication of General Diarrhea in Dogs
6 May 24
News, Press Releases
Napo Pharmaceuticals, a Jaguar Health Family Company, Sponsoring Pediatric Gastroenterology Conference in Abu Dhabi and Panel Discussion About Microvillus Inclusion Disease (MVID)
29 Apr 24
News, Press Releases
Napo Pharmaceuticals, a Jaguar Health Family Company, to Exhibit at Oncology Nursing Society (ONS) Congress in Support of Company's Expanding Focus on Cancer Supportive Care
22 Apr 24
News, Press Releases
Jaguar Health Appoints Biopharmaceutical Industry Veteran to Execute Company's In-licensing Growth Strategy in the Areas of Cancer and GI Supportive Care
18 Apr 24
News, Press Releases
Exploring Stock Surges: Key Insights, Noteworthy BUZZ: KAVL, PRSO, DYAI, WISA, JAGX
16 Apr 24
News, Press Releases
Jaguar Health Licenses FDA-Approved Oral Mucositis Product for U.S. Market, Initiating Commercial Footprint in its Core Focus Area of Cancer Supportive Care
16 Apr 24
News, Press Releases
Jaguar Health Reports Approval of All Proposals at April 2024 Special Meeting of Stockholders
9 Apr 24
News, Press Releases
Jaguar Health Granted Extension Until August 13, 2024, to Regain Compliance with Nasdaq's Bid Price Requirement
8 Apr 24
News, Press Releases
Jaguar Health Appoints European Pharmaceutical Industry Leader as President of Jaguar International
2 Apr 24
News, Press Releases
Jaguar Health Reports 2023 Financial Results
1 Apr 24
Earnings, Press Releases
Jaguar Health to Hold Investor Webcast Monday, April 1st at 8:30 AM Eastern Regarding Q4 2023 Financials & Corporate Updates
27 Mar 24
News, Press Releases
GEN to Commercialize Jaguar Health's Crofelemer in Turkey and Eight Neighboring Countries and Invest $2 Million in Jaguar Stock at 75% Premium to Market
20 Mar 24
Contracts, Press Releases